Skip to main content

Dave IncDE

For the period ended Mar 31, 2024. Filed May 7, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 7, 2024

DAVE$273.85-3.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

For the Three Months Ended March 31,
20242023
Operating activities
Net income (loss)$34,243$(14,025)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization1,7341,200
Provision for credit losses9,94311,953
Changes in fair value of earnout liabilities196(25)
Changes in fair value of public and private warrant liabilities477(146)
Gain on extinguishment of convertible debt(33,442)-
Stock-based compensation6,1306,774
Non-cash interest251759
Non-cash lease expense(5)(6)
Changes in fair value of marketable securities and investments(163)440
Changes in operating assets and liabilities:
Member advances, service based revenue(454)216
Prepaid income taxes1487
Prepaid expenses and other current assets(5,582)(4,061)
Accounts payable2,726(6,891)
Accrued expenses1,9442,617
Legal settlement accrual(2,640)(5,749)
Other current liabilities299(129)
Other non-current liabilities2,543-
Other non-current assets(4)137
Net cash provided by (used in) operating activities18,344(6,929)
Investing activities
Payments for internally developed software costs(1,592)(1,946)
Purchase of property and equipment(12)(264)
Net disbursements and collections of Member advances(1,566)11,853
Purchase of investments(20,889)(5,082)
Sale and maturity of investments90,31565,390
Purchase of marketable securities(59,165)(34,145)
Sale of marketable securities59,034-
Net cash provided by investing activities66,12535,806
Financing activities
Payment for fractional shares on reverse stock split-(13)
Proceeds from issuance of common stock for stock option exercises5241
Repayment of borrowings on convertible debt, long-term(71,000)-
Net cash used in financing activities(70,476)(12)
Net increase in cash and cash equivalents and restricted cash13,99328,865
Cash and cash equivalents and restricted cash, beginning of the period43,07823,677
Cash and cash equivalents and restricted cash, end of the period$57,071$52,542
Supplemental disclosure of non-cash investing and financing activities:
Property and equipment purchases in accounts payable and accrued liabilities$41$61
Supplemental disclosure of cash paid for:
Interest$1,933$2,121
The following table provides a reconciliation of cash and cash equivalents, and restricted cash reported within the condensed consolidated balance sheets with the same as shown in the condensed consolidated statement of cash flows
Cash and cash equivalents$55,525$51,754
Restricted cash1,546788
Total cash, cash equivalents, and restricted cash, end of the period$57,071$52,542
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.